Industry News
In Developing Countries, More Women Dying From Breast And Cervical Cancer At A Younger Age
Sep 15, 2011
The number of cases and deaths from breast and cervical cancer are rising in most countries, especially in the developing world where more women are dying at younger ages, according to a new global analysis by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington... Read More
Gender, Insurance Type Tied To HPV Infection In Laryngeal Cancer Patients
Sep 15, 2011
The human papillomavirus (HPV) is more likely to be found in tumors of laryngeal cancer patients who are male and those with private health insurance, according to a new study from researchers at Henry Ford Hospital... Read More
IUDs May Reduce Cervical Cancer Risk
Sep 13, 2011
Women who use intrauterine devices may not just be preventing pregnancy but may also be protecting themselves from cervical cancer, according to a new study involving more than 20,000 women in different countries that was published in The Lancet Oncology today... Read More
Evaluating The Effectiveness Of Decreased Doses Of Cervical Cancer Vaccine
Sep 12, 2011
Fewer than three doses of the human papillomavirus (HPV) vaccine Cervarix may be just as effective as the standard three-dose regimen when it comes to preventive measures against cervical cancer, according to a new study published September 9 in the Journal of the National Cancer Institute... Read More
HPV Vaccine Cervarix, Two Doses As Good As Three After Four Years
Sep 09, 2011
Two doses of Cervarix, an HPV (human papillomavirus) vaccine were found to be as effective in protecting females from HPV types 16 and 18, which account for 70% of cervical cancer cases, as the standard three doses over a four-year period, researchers have reported in The Journal of the National Cancer Institute... Read More
Screening For HPV Persistence And Cervical Cancer Risk
Sep 08, 2011
Women over the age of thirty who test positive for HPV (Human Papillomavirus) should be re-tested two years later as part of cervical cancer screening, according to a study published online TK in the Journal of the National Cancer Institute... Read More
Cervical Cancer Prevention And Modeling Disparities
Sep 08, 2011
Researchers reported that explicit inclusion of disparities in cost-effectiveness analysis, would allow policy makers to identify strategies that would reduce overall cancer risk, reduce disparities between racial ethnic subgroups, and be cost-effective, according to a study published online September 6 in the Journal of the National Cancer Institute... Read More
Modified Ecstasy May Effectively Treat Leukemia, Lymphoma And Myeloma
Aug 19, 2011
A modified form of Ecstasy (MDMA) may have enormous potential in the treatment of myeloma, lymphoma and leukemia, scientists from the University of Birmingham, England, wrote in the journal Investigational New Drugs. The modified drug is 100 times more powerful as a cancer-busting compound than Ecstacy, which is already known to be effective against over half of white blood cell cancers... Read More
Elacytarabine Combined With Idarubicin Promising For Early Stage AML Patients - Phase II Trial
Aug 19, 2011
Norwegian company, Clavis Pharma ASA, announced promising interim efficacy results from its Phase II clinical investigation with elacytarabine in conjunction with idarubicin in patients with acute myeloid lymphoma (AML) who have failed cytarabine (ara-C)-containing first-course chemotherapy... Read More
Single Flexible Sigmoidoscopy Screening Reduces Colorectal Cancer Incidence And Mortality
Aug 19, 2011
A study published online on yesterday in the Journal of the National Cancer Institute shows, that lower levels of colorectal cancer (CRC) incidence and mortality are linked to a single flexible sigmoidoscopy screening between the ages of 55-64 years... Read More
Previous Page Next Page